Forecast

There is no analyst data available for this company.

News Go to news feed

Synlab announces closure of the Steinlach clinic in Mössingen at end of June

Synlab has confirmed that the Steinlach clinic in the Mössingen health center will close at the end of June and that all employees have been dismissed. The company cited a persistently difficult economic and structural situation, and earlier stabilization measures failed. According to a 2023 quality report, about 19 nursing staff and nine specialist physicians worked there. Synlab emphasizes that medical care in the region remains ensured and emergency services are not affected. » More on t-online.de

Historical dividends Dividends

All dividend metrics All metrics

In 2024, SYNLAB has already paid €0.30 in dividends. The last payout was in May 2024.

Financials

In the last year, SYNLAB had revenue of €2.64bn and net profit of €92.27m

(EUR)	2023	YoY
Revenue	2.64bn	18.93%
Gross profit	569.89m	76.96%
Net profit	92.27m	38.77%
EBITDA	411.43m	57.45%

Fundamentals

Metric	Value
Market capitalization	€2.43bn
Number of shares	219.78m
52-week high/low	€12.43 - €8.02
Dividends	No
Beta	0.89
P/E ratio	26.33
PEG ratio	0.06
P/B ratio	1.04
P/S ratio	0.92

Company profile

Die SYNLAB AG erbringt klinische Labor- und medizinische Diagnosedienstleistungen für Versicherungsgesellschaften, Krankenhäuser, Apotheken, nationale Gesundheitsorganisationen, niedergelassene Ärzte, Kliniken, Patienten, Regierungen und Unternehmen hauptsächlich in Europa. Das Unternehmen bietet Coronavirus-Tests sowie medizinische und veterinärmedizinische Diagnosedienstleistungen an. Es ist mit rund 500 Labors und 1.800 Blutentnahmestellen in 36 Ländern auf vier Kontinenten vertreten. Das Unternehmen wurde 1998 gegründet und hat seinen Hauptsitz in München, Deutschland.